Caris Life Sciences Inc [NASDAQ: CAI] closed the trading session at $24.61 on 2025-11-06. The day’s price range saw the stock hit a low of $24.0, while the highest price level was $29.9999.
If compared to the average trading volume of 727.28K shares, CAI reached to a volume of 5446088 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Caris Life Sciences Inc [CAI]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CAI shares is $39.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CAI stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wolfe Research have made an estimate for Caris Life Sciences Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on July 14, 2025. While these analysts kept the previous recommendation, TD Cowen raised their target price to Buy. The new note on the price target was released on July 14, 2025, representing the official price target for Caris Life Sciences Inc stock. Previously, the target price had yet another raise to $31, while JP Morgan analysts kept a Overweight rating on CAI stock.
The Price to Book ratio for the last quarter was 14.51, with the Price to Cash per share for the same quarter was set at 2.69.
CAI stock trade performance evaluation
Caris Life Sciences Inc [CAI] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -21.05.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CAI stock in for the last two-week period is set at 30.57, with the RSI for the last a single of trading hit 2.41, and the three-weeks RSI is set at 2.08 for Caris Life Sciences Inc [CAI]. The present Moving Average for the last 50 days of trading for this stock 32.02, while it was recorded at 29.00 for the last single week of trading.
Caris Life Sciences Inc (CAI) Capital Structure & Debt Analysis
Caris Life Sciences Inc (CAI) Efficiency & Liquidity Metrics
Based on Caris Life Sciences Inc’s (CAI) latest financial statements, the Debt-to-Equity Ratio is 0.79%, indicating its reliance on debt financing relative to shareholder equity.
Caris Life Sciences Inc (CAI) Efficiency & Liquidity Metrics
Earnings per share (EPS) analysis for Caris Life Sciences Inc [CAI] stock
With the latest financial reports released by the company, Caris Life Sciences Inc posted 0.08/share EPS, while the average EPS was predicted by analysts to be reported at -0.14/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.22. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CAI.
Caris Life Sciences Inc [CAI]: Institutional Ownership
There are presently around $46.29%, or 90.11%% of CAI stock, in the hands of institutional investors.
